Drugs · acquisition-cost intelligence
Synalar
fluocinolone acetonide· ingredient fluocinoloneCorticosteroids· FLUOCINOLONE ACETONIDE .1 mg/g; FLUOCINOLONE ACETONIDE .25 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$1.17
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other fluocinolone products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| DERMA-SMOOTHE/FS | $0.18104 | −$0.99140 |
| fluocinolone acetonide | $0.19523 | −$0.97720 |
| DERMOTIC | $0.96517 | −$0.20730 |
| Synalar | $1.24 | +$0.06640 |
| fluocinolone acetonide | $1.28 | +$0.10650 |
Medicare Part D coverage · CY2026
On 312 plan formularies · typical tier 3
Prior auth 0% · Step therapy 0% · Quantity limit 54% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.